About me
Robyn Bent is the director of CDER’s Patient-Focused Drug Development (PFDD) Program, an effort to systematically obtain patient input and facilitate the incorporation of meaningful patient input into drug development and regulatory decision making. Prior to joining FDA, Robyn held multiple positions at the National Institutes of Health. She has extensive experience in clinical trial design, conduct, and oversight. Robyn earned a Bachelor of Science in Nursing from The Catholic University of America and a Master of Science degree from the George Washington University.
